1887

Journal of Medical Microbiology logo

Volume 72, Issue 5

Expansion of hantavirus infection during the SARS-CoV-2 pandemic in Bosnia and Herzegovina, 2021 Open Access

Abstract

Bosnia and Herzegovina (B and H) has been recognized for decades as a country with a high risk of diseases caused by hantaviruses.

The severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) pandemic has diverted attention from many pathogens, including hantavirus.

To provide a socio-demographic, temporal, geographical and clinical laboratory overview of the expansion of hantavirus infection cases during the SARS-CoV-2 pandemic in B and H in 2021.

The RecomLine HantaPlus IgG, IgM immuno-line assay (Mikrogen, Germany) was used to detect IgG and IgM antibodies to hantavirus serotypes in human sera from clinically suspected cases.

In 2021 (January–October), the number of confirmed cases of hantavirus infection and tested persons (92/140; 65,71 %) was higher than in the previous 2 years, 2020 (2/20; 10.00 %) and 2019 (10/61; 16.39 %). Most of the infected persons were men (84/92; 91.30 %). Hantavirus infections were recorded from January to October 2021, and the peak was reached in July (25/92; 27.17 %). Six out of 10 cantons in the Federation of Bosnia and Herzegovina (FB and H) were affected, namely Sarajevo Canton, Central Bosnia Canton, Neretva Canton, Zenica-Doboj Canton, Posavina Canton and Bosnian-Podrinje Canton Goražde, in descending order. Of the 38/92 (41.30 %) infected patients with characteristic clinical manifestations of haemorrhagic fever, including renal (mainly) or pulmonary syndrome, 32/92 (34.78 %) were hospitalized in the Clinical Center of the University of Sarajevo. Two cases were detected with dual infection, hantavirus (Puumala) with in one and SARS-CoV-2 in another case. The largest number of infections was related to Puumala (PUUV) (83/92; 90.22 %), while the rest of the infections were caused by the hantavirus Dobrava serotype (DOBV).

The reported infections were probably caused by exposure of individuals to at-risk areas inhabited by contaminated rodents as natural reservoirs of hantavirus. As a highly endemic area, B and H requires continuous monitoring and increased awareness of this problem.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): dobrava virus , haemorrhagic fever , hantavirus , infection , puumala virus and SARS-CoV-2
© 2023 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. The Microbiology Society waived the open access fees for this article.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001687
2023-05-31
2024-05-05
Loading full text...

Full text loading...

/deliver/fulltext/jmm/72/5/jmm001687.html?itemId=/content/journal/jmm/10.1099/jmm.0.001687&mimeType=html&fmt=ahah

References

  1. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D et al. Global trends in emerging infectious diseases. Nature 2008; 451:990–993 [View Article] [PubMed]
     [Google Scholar]
  2. Johnson N. A short introduction to disease emergence. In Johnson N. eds The Role of Animals in Emerging Viral Diseases vol 1 Boston, MA, USA, Chapter: Academic Press; 2014 pp 1–19
     [Google Scholar]
  3. Laenen L, Vergote V, Calisher CH, Klempa B, Klingström J et al. Hantaviridae: current classification and future perspectives. Viruses 2019; 11:788 [View Article] [PubMed]
     [Google Scholar]
  4. Meyer BJ, Schmaljohn CS. Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol 2000; 8:61–67 [View Article] [PubMed]
     [Google Scholar]
  5. Watson DC, Sargianou M, Papa A, Chra P, Starakis I et al. Epidemiology of Hantavirus infections in humans: a comprehensive, global overview. Crit Rev Microbiol 2014; 40:261–272 [View Article] [PubMed]
     [Google Scholar]
  6. Toledo J, Haby MM, Reveiz L, Sosa Leon L, Angerami R et al. Evidence for human-to-human transmission of hantavirus: a systematic review. J Infect Dis 2021; 226:1362–1371 [View Article] [PubMed]
     [Google Scholar]
  7. Williams EP, Spruill-Harrell BM, Taylor MK, Lee J, Nywening AV et al. Common themes in zoonotic spillover and disease emergence: lessons learned from bat- and rodent-borne RNA viruses. Viruses 2021; 13:1509 [View Article] [PubMed]
     [Google Scholar]
  8. Center for Disease Control and Prevention (CDC) COVID-19 vs.Hantavirus Pulmonary Syndrome; 2020Aug31 https://www.cdc.gov/hantavirus/resources/covid-vs-hantavirus.html#anchor_1598931865949
  9. Çetin S, Şahin AM. A case of hantavirus infection detected during the COVID-19 pandemic. Klimik Derg 2021; 34:141–143 [View Article]
     [Google Scholar]
  10. Tamerius JD, Wise EK, Uejio CK, McCoy AL, Comrie AC. Climate and human health: synthesizing environmental complexity and uncertainty. Stoch Environ Res Risk Assess 2007; 21:601–613 [View Article]
     [Google Scholar]
  11. Tersago K, Verhagen R, Servais A, Heyman P, Ducoffre G et al. Hantavirus disease (nephropathia epidemica) in Belgium: effects of tree seed production and climate. Epidemiol Infect 2009; 137:250–256 [View Article] [PubMed]
     [Google Scholar]
  12. Heyman P, Vaheri A, Members E. Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. Euro Surveill 2008; 13:18925 [PubMed]
     [Google Scholar]
  13. Hukić M, Muzaferović S, Tulumović D, Calkić L, Sabović S et al. Puumala i dobrava virusi na podrucju sjeveroistocne i srednje bosne [Puumala and dobrava viruses in the northeastern and central regions of Bosnia]. Acta Med Croatica 2003; 57:373–380
     [Google Scholar]
  14. Hukic M, Nikolic J, Valjevac A, Seremet M, Tesic G et al. A serosurvey reveals Bosnia and Herzegovina as a Europe’s hotspot in hantavirus seroprevalence. Epidemiol Infect 2010; 138:1185–1193 [View Article] [PubMed]
     [Google Scholar]
  15. Dervović E, Salimović-Bešić I, Šeremet M, Knežević Z, Dedeić-Ljubović A et al. (2015, April 25-28) The potential impact of climate conditions and catastrophic floods in Bosnia and Herzegovina on expanding hantavirus infection during April-September 2014 [Conference presentation no.ECCMID-0622]. In 25th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark 2015
     [Google Scholar]
  16. Dervović E, Hukić M. Detection of Puumala virus in the tissue of infected naturally rodent hosts in the area of central Dinarides. J Virol Methods 2016; 230:24–27 [View Article] [PubMed]
     [Google Scholar]
  17. Hukić M, Numanović F, Sisirak M, Moro A, Dervović E et al. Surveillance of wildlife zoonotic diseases in the balkans region. medicinski glasnik: official publication of the medical association of zenica-doboj canton. Bosnia Herzegovina 2010; 7:96–105
     [Google Scholar]
  18. Resman Rus K, Kopitar AN, Korva M, Ihan A, Petrovec M et al. Comparison of lymphocyte populations in patients with Dobrava or Puumala orthohantavirus infection. Front Cell Infect Microbiol 2020; 10:566149 [View Article] [PubMed]
     [Google Scholar]
  19. Kallio-Kokko H, Uzcategui N, Vapalahti O, Vaheri A. Viral zoonoses in Europe. FEMS Microbiol Rev 2005; 29:1051–1077 [View Article] [PubMed]
     [Google Scholar]
  20. FAO Law on the protection of the population from infectious diseases. (Article 29); 2005 https://www.fao.org/faolex/results/details/en/c/LEX-FAOC149503
  21. FAO Regulation on the manner for conducting the required disinfection, pest and rodent control. (September 30); 2014 https://www.fao.org/faolex/results/details/en/c/LEX-FAOC149505
  22. FAO Regulation on conditions related to the education of employees, technical equipment, premises and other conditions to be met by health care institutions, corporate entities or natural persons aimed to carry out disinfection, pest and rodent control (September 30); 2014 https://www.fao.org/faolex/results/details/en/c/LEX-FAOC149508
  23. LeDuc JW. Epidemiology of hemorrhagic fever viruses. Rev Infect Dis 1989; 11 Suppl 4:S730–5 [View Article] [PubMed]
     [Google Scholar]
  24. Zeitz PS, Graber JM, Voorhees RA, Kioski C, Shands LA et al. Assessment of occupational risk for hantavirus infection in Arizona and New Mexico. J Occup Environ Med 1997; 39:463–467 [View Article] [PubMed]
     [Google Scholar]
  25. Hart CA, Bennett M. Hantavirus infections: epidemiology and pathogenesis. Microbes Infect 1999; 1:1229–1237 [View Article] [PubMed]
     [Google Scholar]
  26. Sauvage F, Langlais M, Pontier D. Predicting the emergence of human hantavirus disease using a combination of viral dynamics and rodent demographic patterns. Epidemiol Infect 2007; 135:46–56 [View Article] [PubMed]
     [Google Scholar]
  27. Tersago K, Schreurs A, Linard C, Verhagen R, Van Dongen S et al. Population, environmental, and community effects on local bank vole (Myodes glareolus) Puumala virus infection in an area with low human incidence. Vector Borne Zoonotic Dis 2008; 8:235–244 [View Article] [PubMed]
     [Google Scholar]
  28. Kallio ER, Klingström J, Gustafsson E, Manni T, Vaheri A et al. Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol 2006; 87:2127–2134 [View Article] [PubMed]
     [Google Scholar]
  29. European Centre for Disease Prevention and Control Hantavirus infection. In: ECDC. Annual epidemiological report for 2019. Stockholm:ECDC; 2021
  30. Engelthaler DM, Mosley DG, Cheek JE, Levy CE, Komatsu KK et al. Climatic and environmental patterns associated with hantavirus pulmonary syndrome, Four Corners region, United States. Emerg Infect Dis 1999; 5:87–94 [View Article] [PubMed]
     [Google Scholar]
  31. Hjelle B, Glass GE. Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997-1998 El Nino-southern oscillation. J Infect Dis 2000; 181:1569–1573 [View Article] [PubMed]
     [Google Scholar]
  32. Olsson GE, White N, Ahlm C, Elgh F, Verlemyr AC et al. Demographic factors associated with hantavirus infection in bank voles (Clethrionomys glareolus). Emerg Infect Dis 2002; 8:924–929 [View Article] [PubMed]
     [Google Scholar]
  33. Pejcoch M, Kriz B. Ecology, Epidemiology and Prevention of Hantavirus in Europe. In Menne B, Ebi E. eds In Climate Change and Adaptation Strategies for Human Health Steinkopff, Darmstadt; 2006 pp 243–257
     [Google Scholar]
  34. Nikolić J, Kuzman I, Markotić A, Rode OD, Curić I et al. The occurrence of hemorrhagic fever with renal syndrome in southern parts of Bosnia and Herzegovina. Coll Antropol 2009; 33 Suppl 2:37–42 [PubMed]
     [Google Scholar]
  35. Evander M, Eriksson I, Pettersson L, Juto P, Ahlm C et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 2007; 45:2491–2497 [View Article] [PubMed]
     [Google Scholar]
  36. Vaheri A, Vapalahti O, Plyusnin A. How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev Med Virol 2008; 18:277–288 [View Article] [PubMed]
     [Google Scholar]
  37. Lundkvist A, Hukic M, Hörling J, Gilljam M, Nichol S et al. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J Med Virol 1997; 53:51–59 [View Article] [PubMed]
     [Google Scholar]
  38. Hukić M, Tulumović D, Čalkić L, Jahić R, Aganović Mušinović I. (2004, June 23-25). Acute renal failure in hantavirus infections [Conference presentation no.95]. Paper presented at the The 6th International Conference on Hemorrhagic Fever with Renal Syndrome (HFRS) Hantavirus Pulmonary Syndrome (HPS) and Hantaviruses. The National Academy of Sciences. Seoul, Republic of Korea
     [Google Scholar]
  39. Markotić A, Kuzman I, Babić K, Gagro A, Nichol S et al. Double trouble: hemorrhagic fever with renal syndrome and leptospirosis. Scand J Infect Dis 2002; 34:221–224 [View Article] [PubMed]
     [Google Scholar]
  40. Wilson TM, Paddock CD, Reagan-Steiner S, Bhatnagar J, Martines RB et al. Intersecting paths of emerging and reemerging infectious diseases. Emerg Infect Dis 2021; 27:1517–1519 [View Article] [PubMed]
     [Google Scholar]
  41. CDC Diagnosis & Treatment, Hantavirus, DHCPP-CDC; 2012Aug29 https://www.cdc.gov/hantavirus/hps/diagnosis.html
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001687
Loading
Expansion of hantavirus infection during the SARS-CoV-2 pandemic in Bosnia and Herzegovina, 2021
J. Med. Microbiol. 72, 001687 (2023); https://doi.org/10.1099/jmm.0.001687
/content/journal/jmm/10.1099/jmm.0.001687
/content/journal/jmm/10.1099/jmm.0.001687
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error